$WAT

Waters upgraded at Piper Sandler on strong replacement cycle (WAT:NYSE)

Waters Corp. (WAT) rose 1.8% to a 52-week high of $426.22 after Piper Sandler upgraded it to Overweight with a $480 price target, up from $400, citing expected demand recovery.

Original reporting
Published Aug 27, 2026, 6:52 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 7:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$WAT
Bullish
high confidence
Mentioned
$WAT · $PIPR
Relevance
7/10
alphai data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$WATBullishMed
01

Why it matters

Analyst upgrade could trigger short covering and new buying, supporting price gains.

02

Market read

Upgrade-driven price move offers short-term trading opportunity.

03

What to watch

Potential supply chain constraints could temper growth.

Relevance 7/10Novelty 7/10Timing: intraday Thursday

Background

Waters Corp. provides analytical workflow solutions; recent demand recovery noted.

Company-level read

Ticker impact

$WATBullishHigh confidence
Context

Piper Sandler upgraded Waters Corp. to Overweight with a new $480 price target, prompting a 1.8% price rise.

Expected impact

Potential 5-7% upside over the next weeks if target is validated.

Evidence & confidence

Analyst upgrade with a higher price target and a recent price rally indicates fresh bullish sentiment.

Market effects

Positive for analytical workflow and lab equipment sector, may lift peers.

U.S. market, especially biotech and lab services stocks.

Limited to U.S. investors; no broader macro impact.

Counterpoint

Upgrade may be premature if demand recovery stalls.

Key entities

  • Piper Sandler

    Issued the upgrade and new price target.

Related articles

$WATHighAI 8/10

Is Wall Street Bullish or Bearish on Waters Corporation Stock?

Waters Corporation (WAT), a $40.7B life sciences and diagnostics company, reported Q2 2026 adjusted EPS of $3.05 and revenue of $1.65B, exceeding expectations. The stock has risen 43% over 52 weeks, outperforming the S&P 500. Analysts expect 10.9% EPS growth for 2026, with a consensus 'Moderate Buy' rating and a mean price target of $438.43.

$WATMed

WAT Upgraded by Piper Sandler -- Price Target Raised to $480

Piper Sandler upgraded Waters Corporation (WAT) to Overweight, raising its price target to $480 from $400. The company's stock is currently trading at $423.22, slightly above its GF Value™ of $411.65, indicating a 2.8% overvaluation. Waters Corporation has a GF Score™ of 95/100, reflecting strong growth and momentum but moderate financial strength. Insider activity shows recent selling of $1,442,930 worth of shares.

$PIPRMed

Beyond Big Tech: 3 Non-Tech Earnings Winners to Watch

Piper Sandler reported a 25% YOY revenue increase and 17-cent EPS beat, with strong performance in healthcare and investment banking. FTAI Aviation saw 41% YOY revenue growth and 51% adjusted EBITDA increase, driven by aerospace products. Both companies show potential upside for investors, with Piper Sandler (PIPR) and FTAI (FTAI) analysts projecting significant growth.

$UMACMed

Piper Sandler Is Bullish on Unusual Machines Stock. Here's Why.

Piper Sandler initiated coverage of drone maker Unusual Machines (UMAC) with an Overweight rating and a $38 price target. The firm cites FCC restrictions on Chinese-made drones and a $2.1 million defense purchase order, plus component supply opportunities. It flags execution risk as UMAC plans to scale motor capacity from ~15,000 to 100,000 units/month. Q2 revenue rose to $16.72M.